Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.600
-0.010 (-0.62%)
At close: Jul 13, 2026, 4:00 PM EDT
1.560
-0.040 (-2.50%)
Pre-market: Jul 14, 2026, 4:22 AM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $3.65 million as of July 13, 2026. Its market cap has decreased by -94.37% in one year.
Market Cap
3.65M
Enterprise Value
3.78M
1-Year Change
-94.37%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since February 10, 2023, Propanc Biopharma's market cap has increased from $571.43K to $3.65M, an increase of 537.94%. That is a compound annual growth rate of 71.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 3.65M | -49.17% |
| Dec 31, 2025 | 7.17M | 4,231.28% |
| Dec 31, 2024 | 165.57K | -48.84% |
| Dec 29, 2023 | 323.62K | -43.37% |
| Feb 10, 2023 | 571.43K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 4.15M |
| GeoVax Labs | 4.10M |
| Ensysce Biosciences | 3.97M |
| Revelation Biosciences | 3.91M |
| Artelo Biosciences | 3.76M |
| Galmed Pharmaceuticals | 3.70M |
| Onconetix | 3.47M |
| Creative Medical Technology Holdings | 3.37M |